Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine
Pathobiology · 2023
DOI: 10.1159/000528346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathobiology, 2023. Verfasst von Eiichi Morii und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Osaka University, Suita, Japan. Hauptthemen laut MEDLINE: Genomic Medicine, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Rapid advances are being made in cancer drug therapy. Since molecularly targeted therapy has been introduced, personalized medicine is being practiced, pathological tissue from malignant tumors obtained during routine practice is frequently used for genomic testing. Whereas cytological specimens fixed mainly in alcohol are considered to be more advantageous in terms of preservation of the nucleic acid quality and quantity. This article is aimed to share the information for the proper handling of cytological specimens in practice for genomic medicine based on the findings established in “Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine (in Japanese)” published by the Japanese Society of Clinical Cytology in 2021. The three-part practical guidelines are based on empirical data analyses; Part 1 describes general remarks on the use of cytological specimens in cancer genomic medicine, then Part 2 describes proper handling of cytological specimens, and Part 3 describes the empirical data related to handling of cytological specimens. The guidelines indicated proper handling of specimens in each fixation, preparation, and evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Osaka University, Suita, Japan.
- Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
- Department of Pathology, Saitama Cancer Center, Saitama, Japan.
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.
- Clinical Laboratories, Showa General Hospital, Tokyo, Japan.
- Department of Genetic Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
Zitieren
APA
Morii, E., Hatanaka, Y., Motoi, N., Kawahara, A., Hamakawa, S., Kuwata, T., Nagatomo, T., Oda, Y., Okamoto, A., Tanaka, R., Iyoda, A., Ichiro, M., Matsuo, Y., Nakamura, N., Nakai, T., Fukuhara, M., Tokita, K., Yamaguchi, T., Takenaka, M., …, & Working Group on Cytology in the Era of Genomic Medicine (2023). Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine. Pathobiology. https://doi.org/10.1159/000528346
Vancouver
Morii E, Hatanaka Y, Motoi N, Kawahara A, Hamakawa S, Kuwata T, et al. Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine. Pathobiology. 2023. doi:10.1159/000528346
BibTeX
@article{Morii2023,
author = {Morii, Eiichi and Hatanaka, Yutaka and Motoi, Noriko and Kawahara, Akihiko and Hamakawa, Shinji and Kuwata, Takeshi and Nagatomo, Tadasuke and Oda, Yoshinao and Okamoto, Aikou and Tanaka, Ryota and Iyoda, Akira and Ichiro, Maeda and Matsuo, Yukiko and Nakamura, Nobuyuki and Nakai, Tokiko and Fukuhara, Mei and Tokita, Kazuya and Yamaguchi, Tomohiko and Takenaka, Masataka and Kawabata, Ayako and Hatanaka, Kanako C and Tsubame, Kaho and Satoh, Yukitoshi and Working Group on Cytology in the Era of Genomic Medicine, Working Group on Cytology in the Era of Genomic Medicine},
title = {Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine},
journal = {Pathobiology},
year = {2023},
doi = {10.1159/000528346}
}
EUVIMED